| Topographical mapping of isoform-selectivity determinants for J-channel-binding inhibitors of sphingosine kinases 1 and 2 DR Adams, S Tawati, G Berretta, PL Rivas, J Baiget, Z Jiang, A Alsfouk, ... Journal of Medicinal Chemistry 62 (7), 3658-3676, 2019 | 29 | 2019 |
| Rigidity and flexibility of pyrazole, s-triazole, and v-triazole derivative of chloroquine as potential therapeutic against COVID-19 AM Najar, A Eswayah, MB Moftah, MKR Omar, E Bobtaina, M Najwa, ... J Med Chem Sci 6, 2056-2084, 2023 | 27 | 2023 |
| Fabrication and characterization of orodispersible films loaded with solid dispersion to enhance Rosuvastatin calcium bioavailability RM Zaki, M Alfadhel, VDD Seshadri, F Albagami, M Alrobaian, SM Tawati, ... Saudi Pharmaceutical Journal 31 (1), 135-146, 2023 | 10 | 2023 |
| Determinants of parental seasonal influenza vaccine hesitancy in the Eastern Mediterranean region: A cross-sectional study N Fadl, ST Al Awaidy, A Elshabrawy, MSAH Makhlouf, SA Ibrahim, ... Frontiers in Public Health 11, 1132798, 2023 | 9 | 2023 |
| Design, Synthesis, Pharmacological Evaluation and DFT Investigation of New Bioactive Unsymmetrical Bi-Functional Ligand. OR MK, B Eman, J Salem, M Najwa, A Tahani, KA MM Journal of Drug Delivery & Therapeutics 12 (4), 2022 | | 2022 |
| Homology modelling and molecular docking study of TMPRSS2 with small-molecule protease inhibitors to control SARS-CoV-2 SM Tawati, AA Alsfouk, A Alsarrah ACE 2 (2), 3, 2022 | | 2022 |
| Design, synthesis and biological evaluation of sphingosine kinase inhibitors for the treatment of prostate cancer SM Tawati | | 2018 |
| Development of DPP-IV inhibitors for the treatment of type 2 diabetes SM Tawati | | 2011 |
